Objection pursuant to Rule 112: the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (D064213-01)

Date: 18.12.2019 · Reference: B9-0230/2019

Rapporteur: Anja Hazekamp, Tilly Metz, Eleonora Evi · Committee responsible:

Overall Result: 443 For
443 For
216 Against
33 Abstention
56 Did not vote
← Previous Next →
Filter by Country
EPP European People's Party (EPP)
37
123
4
18
Click for details
S&D Progressive Alliance of Socialists and Democrats (S&D)
143
1
1
8
Click for details
NI Non-attached Members (NI)
131
38
25
24
Click for details
Renew Renew Europe (Renew)
72
31
2
3
Click for details
PfE Identity and Democracy (ID)
17
6
0
0
Click for details
GUE/NGL The Left in the European Parliament (GUE/NGL)
13
0
0
0
Click for details
Greens/EFA Greens/European Free Alliance (Greens/EFA)
26
0
0
2
Click for details
ECR European Conservatives and Reformists (ECR)
4
17
1
1
Click for details
← Go back
Follow us on Instagram @checksomevotes @checksomevotes_en